The Use of Propranolol in the Perioperative Period of Resectable Gastrointestinal Tumors

Recruiting Phase 2 Interventional Study
Gastrointestinal Tumors
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Prior Safety Data This treatment has already been tested in at least one earlier human trial.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 65
Sex
Any
Trial phase
Phase 2
Study type
Interventional
Purpose
Treatment
Participants needed
40 (estimated)
Sponsor
Huashan Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

In this study, perioperative propranolol β-blockade was administered to patients with surgically resectable primary gastrointestinal tumors to explore the safety, efficacy, and alleviation of perioperative psychological stress. At the same time, a multi-omics study was conducted using clinical samples to explore the activation of anti-tumor immune response and its mechanism.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Surgically resectable primary gastric cancer and colorectal cancer; 2. Age greater than 18 years old and less than 65 years old; 3. Negative pregnancy test for women of childbearing age; 4. ECOG score ≤2; 5. Signed informed consent. 6. Resting blood pressure greater than 100/…
Contacts

No contact information available.